D009271Chemicals & DrugsD03.132.577.249.706.550D03.549.686.750.550D03.605.497.750.550D04.615.723.795.706.5506110.991493Naltrexoneprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAnesthesiologyDermatologyWake Forest School of MedicineJoshuaNitscheJoshua F. Nitsche MD, PhD36.08959100000000-80.268599000000001118Nitsche, JoshuaAssociate ProfessorJamesEisenachJames C. Eisenach MD36.09003100000000-80.26802800000000269Eisenach, JamesProfessorStevenFeldmanSteven R. Feldman MD, PhD36.08959100000000-80.26859900000000884Feldman, StevenProfessorStephenRappStephen R. Rapp PhD36.09003100000000-80.26802800000000931Rapp, StephenProfessorThomasMartinThomas J. Martin PhD36.08977400000000-80.26684000000000977Martin, ThomasProfessor22263713Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O'Brien CPSubstance abuseCoviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PD, Nunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O'Brien CP. A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Subst Abus. 2012; 33(1):48-59.Subst Abus2012-01-01T00:00:002012A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.25760804Oslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis MJAMA psychiatryOslin DW, Leong SH, Lynch KG, Berrettini W, O'Brien CP, Gordon AJ, Rukstalis M. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial. JAMA Psychiatry. 2015 May; 72(5):430-7.JAMA Psychiatry2015-05-01T00:00:002015Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.27472317Rose JH, Karkhanis AN, Steiniger-Brach B, Jones SRInternational journal of molecular sciencesRose JH, Karkhanis AN, Steiniger-Brach B, Jones SR. Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure. Int J Mol Sci. 2016 Jul 27; 17(8).Int J Mol Sci2016-07-27T00:00:002016Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure.18807246Liu X, Palmatier MI, Caggiula AR, Sved AF, Donny EC, Gharib M, Booth SPsychopharmacologyLiu X, Palmatier MI, Caggiula AR, Sved AF, Donny EC, Gharib M, Booth S. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats. Psychopharmacology (Berl). 2009 Mar; 202(4):589-98.Psychopharmacology (Berl)2008-09-21T00:00:002008Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.Obstetrics and Gynecology, Maternal FetalPsychiatry & Behavioral Medicine23933210Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JHNeuroscience lettersKishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JH. Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neurosci Lett. 2013 Sep 27; 552:98-102.Neurosci Lett2013-08-07T00:00:002013Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor0.7499880.05063816research area of0.5908210.028836744subject area for